-
1
-
-
0031760112
-
Efficacy and adverse events of subcutaneous, oral and intranasal sumatriptan used for migraine treatment: A systematic review based on number needed to treat
-
Oct
-
Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia 1998 Oct:18(8):532-538.
-
(1998)
Cephalalgia
, vol.18
, Issue.8
, pp. 532-538
-
-
Tfelt-Hansen, P.1
-
2
-
-
0343446906
-
Pharmacoeconomics: Measure of cost and benefit
-
Shear NH, Oh PI, Arikian SR. Detsky AS, Laupacis A. Pharmacoeconomics: measure of cost and benefit. Ann R Coll Phys Surg Canada 1995;28:239-240.
-
(1995)
Ann R Coll Phys Surg Canada
, vol.28
, pp. 239-240
-
-
Shear, N.H.1
Oh, P.I.2
Arikian, S.R.3
Detsky, A.S.4
Laupacis, A.5
-
3
-
-
0030009441
-
Subcutaneous sumatriptan for the treatment of migraine: Humanistic, economic, and clinical consequences
-
Mar
-
Cohen JA, Beall DG, Miller DW, et al. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences. Fam Med 1996 Mar:28(3):171-177.
-
(1996)
Fam Med
, vol.28
, Issue.3
, pp. 171-177
-
-
Cohen, J.A.1
Beall, D.G.2
Miller, D.W.3
-
4
-
-
0001001961
-
Pharmacoeconomic impact of injectable sumatriptan on migraine associated healthcare costs
-
Streator SE, Shearer SW. Pharmacoeconomic impact of injectable sumatriptan on migraine associated Healthcare costs. Am J Manag Care 1996;2:67-76.
-
(1996)
Am J Manag Care
, vol.2
, pp. 67-76
-
-
Streator, S.E.1
Shearer, S.W.2
-
5
-
-
0030628845
-
Cost effectiveness of sumatriptan in a managed care population
-
Legg RF, Sclar DA, Nemec NL, Tarnai J, Mackowiak JI. Cost effectiveness of sumatriptan in a managed care population. Am J Manag Care 1997;3:117-122.
-
(1997)
Am J Manag Care
, vol.3
, pp. 117-122
-
-
Legg, R.F.1
Sclar, D.A.2
Nemec, N.L.3
Tarnai, J.4
Mackowiak, J.I.5
-
6
-
-
0031799684
-
Migraine and reduced work performance: A population-based diary study
-
von Korff M, Stewart WF, Simon DJ, Lipton RB. Migraine and reduced work performance: a population-based diary study. Neurology 1998;50:1741-1745.
-
(1998)
Neurology
, vol.50
, pp. 1741-1745
-
-
Von Korff M1
Stewart, W.F.2
Simon, D.J.3
Lipton, R.B.4
-
7
-
-
8544274431
-
A multinational investigation of the impact of subcutaneous sumatriptan III. Workplace productivity and non-workplace activity
-
Cortelli P, Cahlof C Bouchard J, et al. A multinational investigation of the impact of subcutaneous sumatriptan III. Workplace productivity and non-workplace activity. PharmacoEconomics 1997:11(Suppl.1):35-42.
-
(1997)
Pharmacoeconomics
, vol.11
, Issue.SUPPL. 1
, pp. 35-42
-
-
Cortelli, P.1
Cahlof, C.2
Bouchard, J.3
-
8
-
-
0030805079
-
Cost benefit of sumatriptan to an employer
-
Legg RF, Sclar DA, Nemec NL, Tarnai J, Mackowiak JI. Cost benefit of sumatriptan to an employer. JOEM 1997;39(7):652-657.
-
(1997)
JOEM
, vol.39
, Issue.7
, pp. 652-657
-
-
Legg, R.F.1
Sclar, D.A.2
Nemec, N.L.3
Tarnai, J.4
Mackowiak, J.I.5
-
9
-
-
0033057323
-
Indirect costs of migraine in a managed care population
-
Fishman P, Black L. Indirect costs of migraine in a managed care population. Cephalalgia 1999;19:50-57.
-
(1999)
Cephalalgia
, vol.19
, pp. 50-57
-
-
Fishman, P.1
Black, L.2
-
10
-
-
0033027024
-
Incremental absenteeism due to headaches in migraine: Results from the mig-access French national cohort
-
Michel P, Dartigues JF, Duru G, et al. Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort. Cephalalgia 1999;19(5):503-510.
-
(1999)
Cephalalgia
, vol.19
, Issue.5
, pp. 503-510
-
-
Michel, P.1
Dartigues, J.F.2
Duru, G.3
-
11
-
-
0033059144
-
Validation of a migraine work and productivity loss questionnaire for use in migraine studies
-
Davies GM, Santanello N, Gerth W, Lerner D, Block GA. Validation of a migraine work and productivity loss questionnaire for use in migraine studies. Cephalalgia 1999;19(5): 497-502.
-
(1999)
Cephalalgia
, vol.19
, Issue.5
, pp. 497-502
-
-
Davies, G.M.1
Santanello, N.2
Gerth, W.3
Lerner, D.4
Block, G.A.5
-
12
-
-
8544234245
-
A multi-national investigation of the impact of subcutaneous sumatriptan II: Health-related quality of life
-
Dahlof C, Bouchard J, Cortelli P, et al. A multi-national investigation of the impact of subcutaneous sumatriptan II: health-related quality of life. PharmacoEconomics 1997; 11(Suppl.1):24-34.
-
(1997)
Pharmacoeconomics
, vol.11
, Issue.SUPPL. 1
, pp. 24-34
-
-
Dahlof, C.1
Bouchard, J.2
Cortelli, P.3
-
15
-
-
0029127294
-
The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine
-
Tfelt-Hansen P, Henry P, Mulder LJ, et al. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995;346:923-926.
-
(1995)
Lancet
, vol.346
, pp. 923-926
-
-
Tfelt-Hansen, P.1
Henry, P.2
Mulder, L.J.3
-
16
-
-
0026517266
-
A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine
-
The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 1992;32:177-184.
-
(1992)
Eur Neurol
, vol.32
, pp. 177-184
-
-
-
17
-
-
0031921795
-
Tulfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: Comparable effect in a double-blind, randomized, controlled, parallel-group study
-
Myllylä VV, Havanka H, Herrala L, et al. Tulfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache 1998;38:201-207.
-
(1998)
Headache
, vol.38
, pp. 201-207
-
-
Myllylä, V.V.1
Havanka, H.2
Herrala, L.3
-
18
-
-
0025772871
-
A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine
-
The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur Neurol 1991;31:314-322.
-
(1991)
Eur Neurol
, vol.31
, pp. 314-322
-
-
-
19
-
-
0000165169
-
Comparison of the efficacy, safety and tolerability of oral eletriptan and cafergot for the acute treatment of migraine
-
Reches A. Comparison of the efficacy, safety and tolerability of oral eletriptan and cafergot for the acute treatment of migraine. Cephalalgia 1999;19:355.
-
(1999)
Cephalalgia
, vol.19
, pp. 355
-
-
Reches, A.1
-
20
-
-
0033043501
-
Acute treatment of migraine attacks: Efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo
-
The Diclofenac-K/Sumatriptan Migraine Study Group. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. Cephalalgia 1999;19(4):232-240.
-
(1999)
Cephalalgia
, vol.19
, Issue.4
, pp. 232-240
-
-
-
21
-
-
0030905949
-
Guidelines for the diagnosis and management of migraine in clinical practice
-
Pryse-Phillips WEM, Dodick WD, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Can Med Assoc J 1997;156:1273-1287.
-
(1997)
Can Med Assoc J
, vol.156
, pp. 1273-1287
-
-
Pryse-Phillips, W.E.M.1
Dodick, W.D.2
Edmeads, J.G.3
-
22
-
-
0025001986
-
Drug induced headache
-
Mathews NT. Drug induced headache. Neurologic Clinics 1990;8:903-912.
-
(1990)
Neurologic Clinics
, vol.8
, pp. 903-912
-
-
Mathews, N.T.1
-
23
-
-
0033595523
-
An international study to assess reliability of the migraine disability assessment (MIDAS) score
-
Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 1999;53(5):988-994.
-
(1999)
Neurology
, vol.53
, Issue.5
, pp. 988-994
-
-
Stewart, W.F.1
Lipton, R.B.2
Whyte, J.3
-
24
-
-
0032407703
-
Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
-
Tfelt-Hansen P, Teal J. Rodriguez F, et al on behalf of the Rizatriptan 030 Study Group. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Headache 1998;38:748-755.
-
(1998)
Headache
, vol.38
, pp. 748-755
-
-
Tfelt-Hansen, P.1
Teal, J.2
Rodriguez, F.3
|